Rob Lauzon

The American economy is on a path to a soft landing which basically means no major recession and no spectacular growth. There have been little recessions over the last two years in different sectors, eg, the tech sector. He thinks Powell doesn't want a recession and that the market thinks there is now room to push rates lower, anticipating maybe three cuts. Market leadership is broadening out which is a good sign. He could see a 4% to 5% correction which would be healthy for the market and a buying opportunity.

He feels pretty positive about the stock - it has had a nice bounce but is still cheap. E-commerce is still growing in Canada and Cargojet does all the overnight shipping. He expects higher free cash flow and lower debt.

The price of natural gas has been low because of a warm winter. Tourmaline has a very good balance sheet and is a low cost producer. It has exposure to oil and liquids pricing, and he sees it as 1/2 gas and 1/2 oil. If you are looking for just oil stocks, stick with the big ones paying dividends. It could have been his top pick.

It is best for the storage component of AI. He likes the short term outlook and it has been getting traction so you could add at this point. It can be quite volatile.

The question was on his opinion of Telcos. They have been under pressure and performing poorly. They are still spending on Capex but their pricing powers are being lost. There is a real price war on cell phone packages now. Rate cuts in Canada will help dividend payers like BCE to rally. He is definitely not overweight in Telcos.

It is a great business and he likes the business model. The tailwind is volume since it has picked up especially with the weight loss drugs.

He likes it since it has long life reserves of 50 years and a good balance sheet. The world will need energy security, therefore oil and gas production will still be needed. It has had a great run so Cenovus looks a bit cheaper.

He owns lots and just trims his position. Yes other companies could copy its products but at 30 to 40X earnings it is not priced too high. If it reaches $1000 they would be better off to split it. It is a 2 to 3 year hold.

It has quality drugs including a weight loss drug and pays a dividend. There are two main risks, one being that insurance companies may not be able to pay for the weight loss drug until the pricing comes down. Also we don't really know what the side effects are and may not know for another five years. You can buy on weakness for exposure to the sector.

People are once again feeling comfortable going into retirement homes. It now has close to a 90% occupancy rate. He is looking for a price target of $14.

It has neuroscience products, robotic surgery products, etc. People are getting back into having surgeries so it can raise prices. He is looking for better returns in the next while.

It has a high yield and steady 3% growth in free cash flow which gives it a 10% return year over year. A rate cut could take it to over $50. It is the top holding of their firm.

It has struggled and has more debt than others in the sector. He is expecting them to sell off some of their assets which should help, along with rate cuts. The dividend is safe. It is at a good entry point.

It is a GDP grower. There is some volatility since its platform provides private investments to investors and clients. It is a holding company and trades at a 20% discount to the individual assets it holds. It is a well run business at a good valuation. He owns and is accumulating more.

It's always been tough to get this at a reasonable price. It is a good, popular product with longevity. It is getting to a point where you could buy a half position.